Advertisement

ADVERTISEMENT

Pulmonary embolism

Case Report
Saddle Embolus and Right Atrial Clot: Using Catheter-Directed Thrombolysis for Management of Massive Pulmonary Emboli
09/07/2015

Roba S. Alhasan, MD, Osama Qaqi, MD, Mahir Elder, MD, FACC, FSCAI, Director of Endovascular Medicine, Detroit Medical Center, Detroit, Michigan

Roba S. Alhasan, MD, Osama Qaqi, MD, ...
Ultrasound-assisted catheter-directed thromobolysis was seen as the safest therapeutic modality given patient’s increased morbidity and mortality in the event of bleeding.
Ultrasound-assisted catheter-directed thromobolysis was seen as the safest therapeutic modality given patient’s increased morbidity and mortality in the event of bleeding.
Ultrasound-assisted...
09/07/2015
Cath Lab Digest
Case Report
Popliteal Vein Aneurysms
01/26/2015

Roger L. Flekser, BSc, MBBS; Walid Mohabbat, MB BS (Syd) FRACS (Vasc)

North Shore Vein Clinic, Sydney, Australia, and Specialist Vascular Clinic, Sydney, Australia

Roger L. Flekser, BSc, MBBS; Walid Mo...
The authors report a case of a large popliteal aneurysm that resulted in a pulmonary embolus. The diagnosis, and more importantly surgical management, of primary venous aneurysms remain uncertain. This case highlights the diagnosis and...
The authors report a case of a large popliteal aneurysm that resulted in a pulmonary embolus. The diagnosis, and more importantly surgical management, of primary venous aneurysms remain uncertain. This case highlights the diagnosis and...
The authors report a case of a...
01/26/2015
Vascular Disease Management
Clinical Editor's Corner
The Crux Filter: Paradigm Shift in PE Prevention and IVC Filtration?
09/05/2012
Crux Biomedical’s new inferior vena cava filter received 510(k) FDA clearance for U.S. commercialization last month. The device’s novel helical shape was designed to self-center and to conform more closely to the shape of the vena cava, as...
Crux Biomedical’s new inferior vena cava filter received 510(k) FDA clearance for U.S. commercialization last month. The device’s novel helical shape was designed to self-center and to conform more closely to the shape of the vena cava, as...
Crux Biomedical’s new inferior...
09/05/2012
Vascular Disease Management
Interview
Dr. Robert J. Kennedy Described His Study of Ultrasound Accelerated Thrombolysis for the Treatment of Acute PE at ISET 2012
05/29/2012
PE is an undertreated disease in the United States. There are approximately 600,000 cases of pulmonary embolism per year and about 60,000 deaths per year in the U.S. Many of those cases go undiagnosed but of those that are diagnosed, most are...
PE is an undertreated disease in the United States. There are approximately 600,000 cases of pulmonary embolism per year and about 60,000 deaths per year in the U.S. Many of those cases go undiagnosed but of those that are diagnosed, most are...
PE is an undertreated disease in...
05/29/2012
Vascular Disease Management
Interview
Dr. Victor F. Tapson Discussed Submassive PE with VDM at the Veith Symposium 2011
03/30/2012
Risk stratification for pulmonary embolism is extremely important and I think we’ve not tended to do that over the years as this has evolved. Risk stratification shows whether or not a patient can be simply anticoagulated or if they are at...
Risk stratification for pulmonary embolism is extremely important and I think we’ve not tended to do that over the years as this has evolved. Risk stratification shows whether or not a patient can be simply anticoagulated or if they are at...
Risk stratification for...
03/30/2012
Vascular Disease Management
Interview
Dr. David Rosenthal Speaks with VDM at the VEITH Symposium About Bioconvertible IVC Filters for the Prevention of Pulmonary Embolism
02/06/2012
Vena caval filters came about in the early 1970s to prevent pulmonary embolisms. In the 1990s, they developed retrievable filters, but this involved its own risks and costs so we thought that a bioconvertible filter was best for protection...
Vena caval filters came about in the early 1970s to prevent pulmonary embolisms. In the 1990s, they developed retrievable filters, but this involved its own risks and costs so we thought that a bioconvertible filter was best for protection...
Vena caval filters came about in...
02/06/2012
Vascular Disease Management
Interview
Dr. Tod C. Engelhardt Discusses Catheter-Directed, Ultrasound-Accelerated Thrombolysis to Treat Pulmonary Embolism
01/06/2012
Pulmonary embolism can be and frequently is a life-threatening condition and we’re taking patients now with a significant clot burden, a significant degree of debility from pulmonary embolism, and treating them with ultrasound-assisted...
Pulmonary embolism can be and frequently is a life-threatening condition and we’re taking patients now with a significant clot burden, a significant degree of debility from pulmonary embolism, and treating them with ultrasound-assisted...
Pulmonary embolism can be and...
01/06/2012
Vascular Disease Management
Interview
VDM Speaks with Dr. Tod C. Engelhardt About Ultrasonic-Enhanced Thrombolysis for PE
03/08/2011
Dr. Tod C. Engelhardt, Chairman of the Cardiovascular and Thoracic Surgery Division of East Jefferson General Hospital in Metairie, Louisiana, spoke with VDM following his presentation on ultrasonic-enhanced thrombolysis for pulmonary...
Dr. Tod C. Engelhardt, Chairman of the Cardiovascular and Thoracic Surgery Division of East Jefferson General Hospital in Metairie, Louisiana, spoke with VDM following his presentation on ultrasonic-enhanced thrombolysis for pulmonary...
Dr. Tod C. Engelhardt, Chairman...
03/08/2011
Vascular Disease Management
Interview
Latest Study Results from VEITHsymposium on Ultrasound-Accelerated Catheter-Directed Thrombolysis
11/22/2010

Dr. Peter H. Lin 

Dr. Peter H. Lin 
At the recently concluded 37th Annual VEITHsymposium™ in New York, Peter H. Lin, MD, Professor of Surgery and Chief, Division of Vascular Surgery and Endovascular Therapy at Baylor College of Medicine (Houston, Texas), reported his findings...
At the recently concluded 37th Annual VEITHsymposium™ in New York, Peter H. Lin, MD, Professor of Surgery and Chief, Division of Vascular Surgery and Endovascular Therapy at Baylor College of Medicine (Houston, Texas), reported his findings...
At the recently concluded 37th...
11/22/2010
Vascular Disease Management
Editor's Corner
Retrievable IVC Filters: Advance or Gimmick?
09/05/2008

Frank J. Criado

Frank J. Criado
The article by Arko et al describes a first-in-man clinical experience (10 patients) with a new retrievable vena cava filter (VCF). The design of the Crux IVCF appears unique and quite interesting.
The article by Arko et al describes a first-in-man clinical experience (10 patients) with a new retrievable vena cava filter (VCF). The design of the Crux IVCF appears unique and quite interesting.
The article by Arko et al...
09/05/2008
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use